You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    If you are an ASTM Compass Subscriber and this document is part of your subscription, you can access it for free at ASTM Compass

    The NIH Recombinant DNA Advisory Committee: An Example of the Self-Regulatory Process

    Published: 01 January 1990

      Format Pages Price  
    PDF (152K) 9 $25   ADD TO CART
    Complete Source PDF (2.3M) 155 $55   ADD TO CART

    Cite this document

    X Add email address send
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    The National Institutes of Health (NIH) first developed guidelines for the safe laboratory use of recombinant DNA in 1976. The NIH organized the Recombinant DNA Advisory Committee (RAC) to advise and guide work in this area. The RAC consists of biomedical researchers and members from the general public.

    The NIH guidelines have been modified several times since 1976 as new data have become available. This flexibility has enabled the RAC to keep pace with the rapid developments occurring in research and development in this area. The scope, content, and methods of revision of the NIH guidelines are described. The scope and objectives of the RAC are also described. Available data suggest that the RAC has made significant contributions to the field and has created a high degree of confidence among scientists and the public.


    bioprocessing, Recombinant DNA Advisory Committee (RAC), recombinant DNA, NIH Recombinant DNA Advisory Committee, molecular biology, genetic engineering

    Author Information:

    McGarrity, GJ
    Presidentchair, Coriell Institute for Medical ResearchNIH Recombinant DNA Advisory Committee, National Institutes of Health, CamdenWashington, NJD.C.

    Committee/Subcommittee: E48.01

    DOI: 10.1520/STP26063S